Friday, June 24, 2022

Medical Marijuana Inc (OTCMKTS:MJNA) Makes Strides Toward Global Expansion

Medical Marijuana Inc (OTCMKTS:MJNA) is seemingly always at the top of the list when it comes to level of interest among OTC traders. The company has started to stack up a number of catalysts over recent weeks, and its latest direction is perhaps the most interesting dynamic to emerge: a global scope of operations.

Highlighting this, the company recently announced that it has received increasing coverage and recognition for its strides in the country of Brazil. Specifically, MJNA’s subsidiary, HempMeds Brasil, is being touted as “the first company to offer legal medicinal cannabis products to Brazil” after receiving import approval to those suffering from specific medical conditions.

Medical Marijuana Inc (OTCMKTS:MJNA) trumpets itself as an investment holding company that operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high-value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries.

The company licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry. It engages in the research and development of cannabinoid-based pharmaceuticals; and marketing and distribution of cannabidiol hemp oil-based products.

In addition, MJNA provides management support and services to cooperatives, collectives, health and wellness facilities, and medical clinics; and consulting and securities services to businesses and individuals in the legal cannabis industry. Further, it focuses on the treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products.

Medical Marijuana Inc. is the first publicly held company vested in the medical marijuana and industrial hemp markets.

According to company materials, “The company is comprised of a diversified portfolio of products, services, technology and businesses solely focused on the cannabis and hemp industries. These products range from patented and proprietary based cannabinoid products, to seed and stalk or isolated high value extracts specifically manufactured and formulated for the pharmaceutical, nutraceutical and cosmeceutical industries. The Company’s services are extensive and varied, ranging from medical clinic management to the capitalization and development of existing industry business and product leaders. Services include development of cannabinoid based health and wellness products, and the development of medical grade compounds. MJNA provides over 85 proprietary and patented cannabinoid delivery methods that are more socially and medically acceptable than typical industry methods. Finally, MJNA services include the licensing of its proprietary testing, genetics, labeling, and packaging, tracking, production and standardization methods for the medicinal herb industry.”

Medical Marijuana, Inc. was formerly known as Hemp Deposit Distribution Corp. and changed its name to Medical Marijuana, Inc. in March 2011. The company was incorporated in 2003 and is headquartered in Poway, California.

Find out when $MJNA stock reaches critical levels. Subscribe to Right Now by entering your Email in the box below.

According to the company’s most recent release, their array of coverage features a variety of stories highlighting HempMeds Brasil growth, team expansion, and product success. As we know, the path forward for the marijuana sector is going to be largely about “narrative”.

The market for cannabis-related “anything” is a huge growth market of the future, with many forecasters expecting 100-300% growth for the space overall over the next 5-10 years. There is probably no space that can claim as much potential right now. For companies in the cannabis patch, it will seem like a winner-take-all battle for branding in the minds of investors and money managers.

More money will flow in here, and future potential will depend on accessing that capital. We believe those companies that can best present a narrative of increasing opportunities will have greater access to that capital. Medical Marijuana Inc is one of very few in the space taking a tact toward a global scope of operations.

According to its latest release, over the last year, “the company has seen exponential growth. This was no more apparent than when the Brazilian government approved HempMeds Brasil products as a prescription medication for import into the country. In a historic step forward for the nation of Brazil, and the cannabis industry, HempMeds Brasil was permitted to provide Real Scientific Hemp Oil (RSHO) under approval for medical indications. The groundbreaking announcement was reported on around the globe, and stood as a defining mark for HempMeds Brasil. This decision came at the hands of Brazil’s National Health Surveillance Agency, ANIVISA. As reported by Povo and, the result of the monumental import agreement now permits any resident of Brazil who has a government-approved medical indication to gain access to RSHO Hemp Oil Products.”

“We have so much to be proud of and even more to look forward to,” continued Dr. Titus. “The goal of our company is and always has been to put an end to the needless suffering of those around the world. We have set our sights on Brazil as a nation willing to challenge convention in order to set forth progress. Given the historic nature of our import agreement established through ANIVISA, and the success of RSHO-X in Brazil, we look brightly upon the future of HempMeds Brasil as a company intent on making a difference.”

At this time, carrying a capital value in the market of $492M, Medical Marijuana Inc has a stash ($406K) of cash on the books, which is balanced by about $3.9M in total current liabilities. One should also note that debt has been growing over recent quarters. MJNA is pulling in trailing 12-month revenues of $7M. In addition, the company is seeing major top line growth, with y/y quarterly revenues growing at 18.6%. This continues to be a very interesting story and we look forward to updating it again soon. For continuing coverage on shares of $MJNA stock, as well as our other hot stock picks, sign up for our free newsletter today and get our next hot stock pick!

Related Articles


Please enter your comment!
Please enter your name here

Stay Connected


Latest Articles